lunes, 22 de junio de 2026

Amiloidosis cardiaca por transtiretina: Fundamentos para el silenciamiento génico y la estabilización

https://www.medscape.org/viewarticle/transthyretin-amyloid-cardiomyopathy-rationale-silencing-and-2026a1000emm?page=1&uac=148436CN&src=mkmcmr_driv_il_mscpedu_260621_12243870_#transcript-download-es Transthyretin Amyloid Cardiomyopathy: The Rationale for Silencing and Stabilizing Authors: Marianna Fontana, MD, PhD; Caroline Morbach, MD; Ronald Witteles, MD https://www.medscape.org/viewarticle/transthyretin-amyloid-cardiomyopathy-rationale-silencing-and-2026a1000emm?page=2&uac=148436CN&src=mkmcmr_driv_il_mscpedu_260621_&subtitle-lang-code=es https://www.medscape.org/viewarticle/transthyretin-amyloid-cardiomyopathy-rationale-silencing-and-2026a1000emm?page=2&uac=148436CN&src=mkmcmr_driv_il_mscpedu_260621_&subtitle-lang-code=es

No hay comentarios:

Publicar un comentario